Pharmaceutical Company Rankings by Operating income year-over-year growth rate
Compare Japanese listed companies using EDINET financial data across metrics such as revenue, margins, ROE, and growth.
For Pharmaceutical by Operating income year-over-year growth rate, the top 5 companies are Astellas Pharma Inc. (832.4%), SAWAI GROUP HOLDINGS Co., Ltd. (292.4%), Sumitomo Pharma Co., Ltd. (272.6%), MUROMACHI CHEMICALS INC. (71.9%), ONO PHARMACEUTICAL CO., LTD. (54.4%). 39 of 82 companies in the selected population have usable Operating income year-over-year growth rate data. The ranking uses each company’s latest annual data; fiscal periods may differ. Companies ranked sixth and below are also shown in the ranking table below.
Compare industries by Median Operating Income Year-over-Year Growth RateRanking metrics
※ Deposits, lending, and securities investment have a large impact on financial companies, so FCF, FCF margin, and FCF growth may not be suitable for simple comparisons with other industries.
Company ranking chart
Company ranking table
| Rank | Company | Industry | Fiscal year | Operating income year-over-year growth rate |
|---|---|---|---|---|
| 1 | Astellas Pharma Inc. | Pharmaceutical | FY2026 | 832.4% |
| 2 | SAWAI GROUP HOLDINGS Co., Ltd. | Pharmaceutical | FY2026 | 292.4% |
| 3 | Sumitomo Pharma Co., Ltd. | Pharmaceutical | FY2026 | 272.6% |
| 4 | MUROMACHI CHEMICALS INC. | Pharmaceutical | FY2026 | 71.9% |
| 5 | ONO PHARMACEUTICAL CO., LTD. | Pharmaceutical | FY2026 | 54.4% |
| 6 | Otsuka Holdings Co., Ltd. | Pharmaceutical | FY2025 | 48.2% |
| 7 | Daito Pharmaceutical Co., Ltd. | Pharmaceutical | FY2026 | 38.9% |
| 8 | Immuno-Biological Laboratories Co., Ltd. | Pharmaceutical | FY2026 | 34.4% |
| 9 | Fuji Pharma Co.,Ltd. | Pharmaceutical | FY2025 | 28.6% |
| 10 | Mochida Pharmaceutical Co.,Ltd. | Pharmaceutical | FY2026 | 24.9% |
Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.